ClinicalTrials.Veeva

Menu

Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients

A

Assiut University

Status

Unknown

Conditions

Coronary Artery Ectasia

Treatments

Diagnostic Test: Holter, ECG

Study type

Observational

Funder types

Other

Identifiers

NCT05106530
Arrhythmias in CAE patients

Details and patient eligibility

About

The investigators thought to explore arrhythmias outcome - hidden arrhythmias, ECG features: Tp-Te interval and Tp-Te/QTc ratio, fQRS among patients with coronary artery ectasia as compared to normal coronary artery patients.

Full description

All patients will be subjected to:

A. Full history taking:

  • Including age, sex, history of DM, HTN, dyslipidemia and Body surface area.

B. Holter monitoring for 24 hours:

  • Heart rate variability
  • Hidden arrhythmias
  • Hidden ischemia by monitoring ST segment changes

C. Twelve lead ECG:

  • fQRS in baseline ECG
  • QT dispersion.
  • Tp-Te interval and Tp-Te/QTc ratio
  • Tp-Te dispersion

Enrollment

90 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects with suspected CAD who are referred for elective coronary angiography and/or interventions

Exclusion criteria

  1. Patients with a history of cardiomyopathy and myocardial infarction (MI), left ventricular hypertrophy (LVH), pathological Q wave on ECG, typical left bundle block or right bundle block, incomplete right bundle block, or paced rhythm on ECG.
  2. Patients with severe renal impairment
  3. Post CABG patients
  4. Patients of acute coronary syndrome

Trial design

90 participants in 2 patient groups

Coronary Artery Ectasia patients
Treatment:
Diagnostic Test: Holter, ECG
Normal coronary artery patients
Treatment:
Diagnostic Test: Holter, ECG

Trial contacts and locations

1

Loading...

Central trial contact

Mark M N Kamel, Resident; Hamdy Shams El Deen, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems